Company intelligence / Profile preview

Orion Corporation

Espoo, Uusimaa, Finland
Ownership
Public · ORN
Employees
~3880
Development stage
Commercial
01

Overview

Orion has a broad commercial product portfolio with several proprietary and generic medicines on the market. Its pipeline includes investigational candidates in neurology, oncology, and respiratory diseases. The company is expanding into biologics R&D and antibody therapeutics through recent partnerships.[2][5]

Therapeutic areas
PulmonologyCardiovascularNeurology
Modalities
Small moleculesInhaled drugs (Easyhaler® device portfolio)Antibody therapeutics (recent partnerships)
Industry
Biotech
02

Drug pipeline

25 assets

entacapone

Approved

24 more assets in the full pipeline.

Request access →
03

Partnerships

Bayer AG – co-development of Nubeqa/darolutamide for prostate cancer [2][7]Abilita Therapeutics – antibody therapeutics partnership in oncology/pain management [2]Aitia – digital twins technology partnership for cancer research [2]
04

Financials

Market cap
$368.1M
Total revenue
$221.9M
Enterprise value
$514.4M

Beyond the preview

Go deeper on Orion Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orion Corporation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call